The Hyaluronan/CD44 Axis: A Double-Edged Sword in Cancer
International Journal of Molecular Sciences · 31.10.2023 · 24 (21) · 15812
DOI: 10.3390/ijms242115812 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 31.10.2023. Verfasst von Nicola Cirillo. Beteiligte Einrichtung: Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, 720 Swanston Street, Carlton, VIC 3053, Australia. Hauptthemen laut MEDLINE: Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 109-mal zitiert (Crossref) und nennt 129 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Hyaluronic acid (HA) receptor CD44 is widely used for identifying cancer stem cells and its activation promotes stemness. Recent evidence shows that overexpression of CD44 is associated with poor prognosis in most human cancers and mediates therapy resistance. For these reasons, in recent years, CD44 has become a treatment target in precision oncology, often via HA-conjugated antineoplastic drugs. Importantly, HA molecules of different sizes have a dual effect and, therefore, may enhance or attenuate the CD44-mediated signaling pathways, as they compete with endogenous HA for binding to the receptors. The magnitude of these effects could be crucial for cancer progression, as well as for driving the inflammatory response in the tumor microenvironment. The increasingly common use of HA-conjugated drugs in oncology, as well as HA-based compounds as adjuvants in cancer treatment, adds further complexity to the understanding of the net effect of hyaluronan-CD44 activation in cancers. In this review, I focus on the significance of CD44 in malignancy and discuss the dichotomous function of the hyaluronan/CD44 axis in cancer progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, 720 Swanston Street, Carlton, VIC 3053, Australia.
ORCID-Profile: Nicola Cirillo
Zitieren
APA
Cirillo, N. (2023). The Hyaluronan/CD44 Axis: A Double-Edged Sword in Cancer. International Journal of Molecular Sciences, 24(21), 15812. https://doi.org/10.3390/ijms242115812
Vancouver
Cirillo N. The Hyaluronan/CD44 Axis: A Double-Edged Sword in Cancer. International Journal of Molecular Sciences. 2023;24(21):15812. doi:10.3390/ijms242115812
BibTeX
@article{Cirillo2023,
author = {Cirillo, Nicola},
title = {The Hyaluronan/CD44 Axis: A Double-Edged Sword in Cancer},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {21},
pages = {15812},
doi = {10.3390/ijms242115812}
}
EUVIMED